logo
France attacks Trump ‘diktak' on DEI

France attacks Trump ‘diktak' on DEI

Yahoo30-03-2025

France has accused Donald Trump of 'interference' after the White House demanded that European companies working with the US government drop diversity schemes.
Companies in France and other EU countries have received letters in recent days warning that Mr Trump's executive order on diversity, equity and inclusion (DEI) schemes applied to companies outside the United States.
The order bans companies with federal contracts from operating 'illegal' DEI programmes. The letter from the US embassy in Paris says this 'applies to all suppliers and service providers of the US Government, regardless of their nationality and the country in which they operate'.
Aurore Bergé, France's equality minister, called the letter a 'diktat', and said that French companies would not sign up to its demands.
Ms Bergé told French broadcaster BFMTV: 'The letter is a form, obviously, of interference. That's to say it's an attempt to impose a diktat on our businesses.'
She said that many companies do not intend to respond to what is 'a sort of ultimatum laid out by the US embassy in our country'.
'It's out of the question that we'll prevent our businesses from promoting social progress,' she added. 'Thankfully, a lot of French companies don't plan to change their rules.'
Ms Bergé later tweeted: 'We have principles and laws and we intend that they be respected, despite what the US Embassy says.'
The US letter, which emerged on Friday, demands that companies return a form in five days confirming that they are complying with the order.
Companies must confirm they 'are in compliance in all respects with all applicable Federal anti-discrimination laws', and that they 'do not operate any programmes promoting diversity, equity and inclusion that violate any applicable federal anti-discrimination laws'.
UK companies are not believed to have received a similar letter. The US embassy in London did not respond to a request for comment on whether it planned to send similar letters to companies in the UK.
BAE Systems, Rolls-Royce, BP and GSK are all among the US Government's top 100 federal contractors, according to the General Services Administration.
GSK said in February that it was dropping diversity activities in order to continue work for the US government.
This weekend, it emerged that WPP, the London-based advertising giant, had dropped references to DEI from its latest annual report as Mr Trump campaigns against the policies. The omissions were first reported by the Sunday Times.
UK branches of companies including McDonald's and Deloitte have kept DEI policies despite their US counterparts scrapping them.
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CDC Director Nominee Pledges to Refocus Agency, Support MAHA Agenda
CDC Director Nominee Pledges to Refocus Agency, Support MAHA Agenda

Epoch Times

time12 minutes ago

  • Epoch Times

CDC Director Nominee Pledges to Refocus Agency, Support MAHA Agenda

President Donald Trump's new nominee to lead the Centers for Disease Control and Prevention told senators on June 25 that she would refocus the agency to tackle infectious diseases but still look to support the Make America Healthy Again, or MAHA, agenda promoted by Trump and Health Secretary Robert F. Kennedy Jr. 'As CDC refocuses its efforts specifically on communicable diseases ... we'll be laser-focused on that area, but we will continue, and I will continue, to make sure that we're supporting the secretary's vision of overall Making America Healthy Again,' Susan Monarez, the nominee to lead the CDC, said during her confirmation hearing in Washington.

Democratic-led states sue Trump administration over funding cuts
Democratic-led states sue Trump administration over funding cuts

The Hill

time36 minutes ago

  • The Hill

Democratic-led states sue Trump administration over funding cuts

A group of 21 Democratic-led states filed a Tuesday lawsuit against the Trump administration for arbitrarily cutting grants allegedly misaligned with an agency's goals. Plaintiffs, which include New York, Illinois and California, said federal agencies have taken on a nationwide 'slash-and-burn campaign' to unlawfully revoke previously awarded funds through a subclause in federal regulations. States' attorneys general allege a clause permitting federal agencies to terminate grants 'pursuant to the terms and conditions of the Federal award, including, to the extent authorized by law, if an award no longer effectuates the program goals or agency priorities' is being misused by the Trump administration. The states said congressionally mandated funds cannot be 'stripped away' to punish jurisdictions that enforce policies disliked by the current administration. States with sanctuary cities, research projects related to environmental protection standards and other measures have lost federal dollars in recent months. 'With the stroke of a pen, federal agencies have deprived States of critical funding they rely on to combat violent crime and protect public safety, equip law enforcement, educate students, safeguard public health, protect clean drinking water, conduct life-saving medical and scientific research, address food insecurity experienced by students in school, ensure access to unemployment benefits for workers who lose their jobs, and much more,' plaintiffs wrote in the lawsuit. 'Federal agencies have done all of this without any advance notice, without any explanation to the State recipients, and in direct contravention of the will of Congress,' they added. 'The State recipients' sole offense has been that they used the grant funding precisely how they had promised in the grant applications—and as they were instructed by the agencies at the time of the grant award.' 'Leftist AGs and governors who would rather spend their days drafting toothless letters in an attempt to 'stick it to Trump' continue to miss the mark while failing to address real issues impacting their states,' White House principal deputy press secretary Harrison Fields told The Hill. 'Every one of these elected officials should focus on serving their constituents, not their party bosses, and work with the President and this administration to enact the agenda the American people overwhelmingly supported.' The lawsuit follows a federal judge's Thursday ruling rejecting the Department of Transportation's attempts to tie state funding to immigration enforcement operations.

Bondholders approve amended terms of the 2025 and 2028 convertible bonds
Bondholders approve amended terms of the 2025 and 2028 convertible bonds

Yahoo

time36 minutes ago

  • Yahoo

Bondholders approve amended terms of the 2025 and 2028 convertible bonds

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – June 25, 2025Idorsia Ltd. (SIX: IDIA) today announced the positive outcome of two bondholder meetings held at 17:30 CEST and 19:00 CEST on June 25, 2025. The bondholder meetings for holders of Idorsia's outstanding CHF 200 million convertible bonds maturing in 2025 (CB 2025; ISIN CH0426820350), and CHF 600 million convertible bonds maturing in 2028 (CB 2028; ISIN CH1128004079) were held to vote on the amendments to the terms of the CB 2025 and CB 2028, including an extension of the maturity date of the CB 2025 to July 17, 2034, and the maturity of the CB 2028 to August 4, 2038. 89.5% of the holders of the CB 2025 and 93.5% of the holders of the CB 2028 voted in favor of the amendments – significantly exceeding the required two thirds majority thresholds. The amendments to the CB 2025 and CB 2028 terms will become binding and effective upon approval by the higher cantonal composition authority (obere kantonale Nachlassbehörde) and are conditional on the consummation of the repurchase offer for the CB 2025 and CB 2028, which was launched on June 25, 2025. All information related to the bondholder meetings and amended terms can be found at the following links: and Notes to the editor About IdorsiaIdorsia Ltd is reaching out for more – we have more passion for science, we see more opportunities, and we want to help more patients. The purpose of Idorsia is to challenge accepted medical paradigms, answering the questions that matter most. To achieve this, we will discover, develop, and commercialize transformative medicines – either with in-house capabilities or together with partners – and evolve Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from bench to bedside; QUVIVIQ™ (daridorexant), a different kind of insomnia treatment with the potential to revolutionize this mounting public health concern; strong partners to maximize the value of our portfolio; a promising in-house development pipeline; and a specialized drug discovery engine focused on small-molecule drugs that can change the treatment paradigm for many patients. Idorsia is listed on the SIX Swiss Exchange (ticker symbol: IDIA). For further information, please contactInvestor & Media RelationsIdorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, CH-4123 Allschwil+41 58 844 10 – – The above information contains certain "forward-looking statements", relating to the company's business, which can be identified by the use of forward-looking terminology such as "estimates", "believes", "expects", "may", "are expected to", "will", "will continue", "should", "would be", "seeks", "pending" or "anticipates" or similar expressions, or by discussions of strategy, plans or intentions. Such statements include descriptions of the company's investment and research and development programs and anticipated expenditures in connection therewith, descriptions of new products expected to be introduced by the company and anticipated customer demand for such products and products in the company's existing portfolio. Such statements reflect the current views of the company with respect to future events and are subject to certain risks, uncertainties and assumptions. Many factors could cause the actual results, performance or achievements of the company to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated or expected. Attachment Press Release PDF

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store